Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab and HPV Vaccine in Recurrent/Metastatic Cervical Cancer
NCT04096911Phase 2Unknown
- Start
- Jul 2019
- Primary completion
- Mar 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in Cervical Cancer (CC). Status: unknown.
02
Drugs
sintilimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04096911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04096911.